JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis

Meta-analysis (6 cohort studies, 5 clinical trials n=2367) found JAK-inhibitors decreased invasive mechanical ventilation (P = 0.002), had borderline impact on ICU admission (P = 0.05) and acute respiratory distress syndrome (P = 0.16) and did not decrease hospital stay (P=0.94)

Source:

Leukemia